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Assembly of tau protein into paired helical filaments and straight filaments is a key feature of Alzheimer's
disease. Aggregation of tau has been implicated in neurodegeneration, cellular toxicity and the propagation,
which accompanies disease progression. We have reported previously that a region of tau (297–391),
referred to as dGAE, assembles spontaneously in physiological conditions to form paired helical filament-like
fibres in vitro in the absence of additives such as heparin. This provides a valuable tool with which to explore
the effects of tau in cell culture. Here we have studied the cellular uptake of soluble oligomeric and fibrillar
forms of dGAE and examined the downstream consequences of tau internalisation into differentiated SH-
SY5Y neuroblastoma cells using fluorescence and electron microscopy alongside structural and biochemical
analyses. The assembled dGAE shows more acute cytotoxicity than the soluble, non-aggregated form.
Conversely, the soluble form is much more readily internalised and, once within the cell, is able to associate
with endogenous tau resulting in increased phosphorylation and aggregation of endogenous tau, which
accumulates in lysosomal/endosomal compartments. It appears that soluble oligomeric forms are able to
propagate tau pathology without being acutely toxic. The model system we have developed now permits the
molecular mechanisms of propagation of tau pathology to be studied in vitro in a more physiological manner
with a view to development of novel therapeutic approaches.
© 2020 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license (http://
creativecommons.org/licenses/by/4.0/).Introduction
A common pathological process amongst neurode-
generative diseases is the accumulation of amyloid
aggregates formed by disease-specific proteins in the
cytoplasm, nucleus or extracellular space [1]. The
misfolding, self-assembly and accumulation of tau
protein in neurofibrillary tangles is a major pathological
feature shared by tauopathies, the most common of
which is Alzheimer's disease (AD). Under pathologicaluthors. Published by Elsevier Ltd. This
ses/by/4.0/).
s: S. J. Pollack, J. Trigg, T. Khanom, et
au Protein and Accumulates in A..., Journaconditions, the abnormal aggregation of tau protein into
paired helical filaments (PHFs) that constitute the
neurofibrillary tangles is accompanied by the loss of
function of tau protein and neuronal dysfunction.
The identity of the speciesof tau that ismost toxic has
been debated [2–5]. It was thought that neurofibrillary
tangles are an integral feature of tau toxicity, since their
number and distribution in the brain correlate with
cognitive decline in AD [6–8]. However, as with other
amy l o i d o g e n i c p r o t e i n s imp l i c a t e d i nis an open access article under the CC BY license (http://
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2 Tau297-391 (dGAE) influences endogenous Tauneurodegeneration, it has been proposed that tau
oligomers are the toxic species responsible for the
correlation between lesions and neurodegeneration
[9–13]. Hypotheses regarding oligomeric tau toxicity
have been suggested based on commonmechanisms
of toxicity shared amongst amyloid proteins, including
mitochondrial dysfunction, increase in ion permeability
ofmembranes, increased intracellular calcium, leakage
of cellular contents, and dysfunction of the autophagy-
lysosomal machinery [14,15].
Tau has been shown to exhibit prion-like propa-
gation, including cellular uptake and templated
seeding [16–22]. In vitro studies have shown that
extracellular tau aggregates can be internalised by
neurons to induce self-assembly of intracellular
endogenous tau, which can then be released and
transferred to neighbouring or synaptically connect-
ed neurons [23–26]. In cultured cell lines, interna-
lised aggregates of recombinant tau induced using
heparin or AD brain-derived tau aggregates can be
observed in endosomal compartments and are
capable of recruiting endogenous and aggregation-
prone tau to aggregate [16,19,23,25–28]. A consis-
tent finding in these studies is the colocalisation of
tau with endosomes and lysosomes [19,23,24,26].
Whilst there is strong support for transmission of tau
aggregates between neurons and/or glial cells, the
species responsible for this has been debated. Studies
have suggested that the seeding competence of tau is
dependent on the size and conformation of the tau
aggregate and that tau oligomers act as the key
species for inducing propagation [13] rather than
monomers or longer fibrils purified from rTg4510 mice
[26]. It was reported in one study that large tau
aggregates (N10 mers) are the seed-competent
species in P301S tau transgenic mice [29], whereas
in another study, tau trimers were found to be the
minimal unit necessary for conformational template
seeding and intracellular tau aggregation in human tau-
expressing HEK-293 cells [30].
Many studies have used animal or cell models in
which human and/or mutant tau has been over-
expressed. In vitro studies have utilised full-length or
truncated tau proteins that require heparin-induced
fibrillisation. Both approaches aim to overcome the
low aggregation propensity and the lack of cytotox-
icity of full-length tau [31]. However, there are
increasing doubts as to the physiological relevance
of heparin-induced tau filaments as they do not
reproduce the key self-assembly or structural fea-
tures of AD filaments [32–34]. The truncated repeat-
domain fragment of tau spanning residues 297–391
(referred to as dGAE (see [33–37] for nomencla-
ture)), which was first identified biochemically in
proteolytically stable PHF core preparations from AD
brain tissues [35–37], includes the core sequence
(306–378) characterised by cryo-electron microsco-
py as forming C-shaped subunits assembled to form
a combined cross-β/β-helix structure [38]. It is notPlease cite this article as: S. J. Pollack, J. Trigg, T. Khanom, et
Influences Endogenous Tau Protein and Accumulates in A..., Journaunderstood what initiates the process of tau aggre-
gation in AD, but truncated dGAE serves for
template-directed aggregation of tau in cell-free
and cellular models [22,39] and in transgenic mice
[40]. In previous work, we have reported that under
certain conditions, dGAE readily assembles into
amyloid-like fibrils that are morphologically similar to
native PHFs in vitro without the need for exogenous
seeding factors [41,42]. This provides a useful model
system with which to explore cellular effects of this
core tau region in the form of soluble or fibrillar
aggregates. Here we have developed the use of a
fluorescently labelled version of dGAE to study its
internalisation and downstream toxic effects in
differentiated human neuroblastoma cells (dSH-
SY5Y) expressing endogenous, full-length human
tau at normal levels.
We report here that aggregated dGAE is cytotoxic
whilst the soluble, non-fibrillar dGAE is not acutely toxic
and is taken up by neuron-like cells. Internalisation
results in production of insoluble tau species, abnormal
phosphorylation and truncation of endogenous full-
length tau. Immunofluorescence and immunogold
transmission electron microscopy (TEM) of treated
cells reveals that dGAE accumulates within the
endosomal/lysosomal compartments.Materials and Methods
Preparation of recombinant dGAE
Purified recombinant truncated tau (dGAE, corre-
sponding to amino acid residues 297–391 using
numbering from 2N4R tau) was used throughout the
study. Recombinant tau protein 297–391 was purified
as previously described [41]. Following purification,
dGAE exists in a predominantly random coil confor-
mation and consists mainly of soluble monomer and
dimer as previously characterised and described [41].
Alexa Fluor® 488 labelling of tau protein
To generate fluorescently tagged tau protein (dGAE-
488), dGAE was covalently labelled with Alexa Fluor
488® (Life Technologies) by mixing 200 μl protein
(425.2 μM) with 10 μl 113 nM Alexa Fluor® TFP ester
and 20 μl 1 M sodium bicarbonate (pH 8.3). The
mixture was left to incubate in the dark for 15 min at
room temperature. Zeba 7K MWCO columns (Thermo
Scientific) were equilibrated by adding 1 ml 10 mM
phosphate buffer (pH 7.4) and centrifuging at 1000g for
2 min at 4 °C. The eluate was discarded and the
process was repeated three times. The protein/dye
mixture was added drop-wise onto the top of the
column immediately followedby40 μl phosphate buffer
and was centrifuged at 1000g for 2 min at 4 °C. The
protein solution was kept on ice and the absorbance atal., Paired Helical Filament-Forming Region of Tau (297–391)
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3Tau297-391 (dGAE) influences endogenous Tau280 nm (A280) was measured using a NanoDrop
spectrophotometer. The protein concentration was
calculated using the A280, and the molar extinction
coefficient of dGAE (1400 cm−1 M−1) taking into
account the absorption of the dye at A494. dGAE has
14 lysine residues, which are all potential sites at which
the 488 dye can bind. The extent of labelling was
determined by the A494 and the molar extinction
coefficient of the dye (71,000 cm−1 M−1). The protein
(dGAE-488) was used immediately for subsequent
experiments or subjected to agitation in vitro.
In vitro assembly of dGAE and dGAE-488
In vitro assembly of dGAE and dGAE-488 was
performed as previously described [41] without
reducing agent. Briefly, 100 μM protein was diluted
in 10 mM phosphate buffer (pH 7.4) and incubated
at 37 °C whilst agitating with a speed of 700 rpm on
an Eppendorf ThermoMixer® for 72 h. Samples
were visualised using negative-stain TEM. All
experiments were conducted using the stock
100 μM dGAE in phosphate buffer.
Negative-stain TEM
Aliquots (4 μl) of dGAE assembly mixtures
(100 μM in phosphate buffer (pH 7.4)) were placed
on 400-mesh carbon-coated grid and incubated for
1 min. After removing excess solution with filter
paper, the grid was washed with 4 μl filtered Milli-Q
water for 1 min and blotted. The grids were
negatively stained with 4 μl filtered 2% (w/v) uranyl
acetate for 1 min, blotted dry and left to air dry for at
least 5 min. Grids were examined on a JEOL
JEM1400-Plus Transmission Electron Microscope
at 100 kV and electron micrograph images were
collected using 4k × 4k One View (Gatan) camera.
Circular dichroism spectroscopy
Circular dichroism (CD) spectroscopy was per-
formed using a Jasco Spectrometer J715 and
spectra were collected in triplicate at a maintained
temperature of 21 °C. Protein samples were placed
into 0.02-mm path-length quartz cuvettes (Hellma)
and scanned from 180 to 320 nm. CD data were
converted to molar ellipticity (deg·cm2·dmol−1).
Cell culture and dGAE treatment
Undifferentiated SH-SY5Y human neuroblastoma
cells were grown in Dulbecco's modified Eagle
medium/Nutrient Mixture F-12 (DMEM/F-12) supple-
mented with 10% foetal calf serum, 1% penicillin/
streptomycin (P/S) and 1% L-glutamine. For differenti-
ation, SH-SY5Y cells were plated at a density of 50,000
cells per well in 24-well plates or 300,000 cells per well
in 6-well plates. For immunofluorescence, cells werePlease cite this article as: S. J. Pollack, J. Trigg, T. Khanom, et
Influences Endogenous Tau Protein and Accumulates in A..., Journaplated onto Menzel-Gläser coverslips (Thermo Scien-
tific). For live-cell imaging, cells were plated on 35-mm
dishes on a 1.5-mm coverslip (Mattek). On the first day
of differentiation, media was replaced with low-serum
culture media (DMEM/F-12 containing 1% foetal calf
serum, 1% P/S and 1% L-glutamine) containing 10 μM
all-trans retinoic acid (RA) (Sigma-Aldrich) and cells
were incubated for 48 h. On day 3, this process was
repeated with fresh RA and cells were incubated for a
further 48 h. On day 5, the cells were washed once in
serum-free culture media to remove traces of serum.
Serum-free culture media (DMEM/F-12 containing 1%
P/S and 1% L-glutamine) containing 50 ng/ml brain-
derived neurotrophic factor (STEMCELL Technolo-
gies) was added to the cells and incubated for 48 h.
Differentiated cells (dSH-SY5Y) were ready to use for
experiments on day 7. For dGAE treatment, cells were
exposed to 1 μMdGAE (either solublewithout agitation
or after agitation) and incubated for 24 h. All exper-
iments were conducted using dSH-SY5Y cells.
Cell viability assay
Following the addition of dGAE, cell viability was
measured using ReadyProbes® Cell Viability Imag-
ing Kit (Life Technologies). The kit contains a
NucBlue® reagent to label all cells (blue) and a
NucGreen® reagent to label dead cells only (green).
For tagged dGAE, NucRed® reagent was used to
label dead cells (red). One drop of each reagent was
added to cells in 500 μl media as described in the
manufacturers protocol (Life Technologies). Cells
were incubated with the reagents at 37 °C for 15 min
and the media was replaced with Live Cell Imaging
Solution (Invitrogen™, Thermo Scientific). Cells
were imaged using a Zeiss Cell Observer Axiovert
200 M microscope. DAPI fluorescence was cap-
tured using a G 365 excitation filter and a LP 420
emission filter with a FT 395 dichroic. Green
fluorescence was captured using a FITC filter set
(BP 450–490 excitation filter, BP 515–565 emission
filter and FT 510 dichroic). Identical acquisition
settings were used for all replicates, and images
were analysed using FIJI. Six fields of view were
taken per sample, and an average of 4500 cells were
analysed per condition. The proportion of buffer-
treated cell death was quantified by converting the
images to grayscale followed by manually adjusting
the threshold and converting it into a binary image to
highlight live DAPI-stained cells. The number of cells
was automatically counted. The dead cells were
counted in the same way, and cell death was
expressed as a percentage .
Cell lysis and fractionation
Cells were detached from the coverslip by incubation
in 0.25% trypsin–EDTA (Gibco™) and then mixed with
5 ml culture media. The cells were harvested byal., Paired Helical Filament-Forming Region of Tau (297–391)
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4 Tau297-391 (dGAE) influences endogenous Taucentrifugation at 500g for 5 min, and the supernatant
was discarded. The cell pellet was resuspended in ice-
cold PBS and centrifuged at 500g at 4 °C. Cells were
lysed in 1% Triton lysis buffer (1% Triton X-100 (v/v),
150 mM NaCl and 50 mM Tris–HCl (pH 7.6)) contain-
ing Halt™ protease inhibitors (Thermo Scientific) and
phosphatase inhibitors (Thermo Scientific) for 15 min
on ice. The samples were centrifuged at 16,000g for
30 min at 4 °C, and the supernatant was collected
(Triton-soluble fraction). The pellet was suspended in
SDS lysis buffer (1% SDS (w/v), 150 mM NaCl and
50 mM Tris–HCl (pH 7.6)) containing protease and
phosphatase inhibitors. The samples were centrifuged
at 16,000g for 30 min at room temperature, and the
supernatant was collected (Triton-insoluble fraction).
Protein concentration in the Triton-soluble fractions was
determined using the Pierce™ BCA Protein Assay Kit
(Thermo Scientific) according to the manufacturer's
instructions.
SDS-PAGE and Western blotting
For cell lysates, Triton-soluble protein (20 μg)
and an equal volume of Triton-insoluble protein
were each mixed with Læmmli sample buffer (4×)
(Bio-Rad Laboratories) containing 5% (v/v) β-
mercaptoethanol and heated at 95 °C for 5 min.
For recombinant protein, 3 μg was mixed with
sample buffer without reducing agent or boiling. All
samples were centrifuged for 5 min at 1000g, and
samples were loaded onto 4–20% Mini-PROTEAN®
precast gels (Bio-Rad Laboratories) and run at
120 V for 1 h in Tris-glycine running buffer (25 mM
Tris, 192 mM glycine (pH 8.3)), or until the sample
buffer reached the end of the gel. For Coomassie
staining, the gel was washed three times in double
distilled water for 5 min and stained with Imperial™
protein stain (Thermo Scientific) for 1 h and then
destained overnight in double distilled water. The
stained gel was scanned using an HP Photosmart
C5280 scanner. For western blotting, the separated
proteins on the gel were transferred to nitrocellulose
membrane (0.45 μm) at 200 mA for 90 min. The
membranes were blocked in 5% (w/v) bovine serum
albumin (BSA) in Tris-buffered saline (50 mM Tris–
HCl (pH 7.4), 150 mM NaCl) containing 0.1% (v/v)
Tween-20 (TBS-T) for 1 h rocking at room temper-
ature. Membranes were incubated with primary
antibodies diluted in 5% BSA in TBS-T overnight at
4 °C. The following primary antibodies and dilutions
were used: Anti-Tau (polyclonal, total tau) (Thermo
Scientific) (1:2500), AT180 (anti-pT231) (Thermo
Scientific) (1:1000), AT8 (anti-pS202-T205) (1:1000)
(Thermo Scientific), and anti-GAPDH (1:5000)
(Abcam). The next day, membranes were incubated
in horseradish peroxidase–anti-mouse antibody
(1:5000) (Sigma-Aldrich) or horseradish peroxidase–
anti-rabbit antibody (1:5000) (Abcam) in 5%BSAw/v in
TBS-T for 1 h at room temperature. The membranesPlease cite this article as: S. J. Pollack, J. Trigg, T. Khanom, et
Influences Endogenous Tau Protein and Accumulates in A..., Journawere washed 3 × 10 min in TBS-T between antibody
incubations. Immunoreactive protein bands were de-
tected using ECL substrate (Clarity™, Bio-Rad), and X-
ray filmswere scanned using anHPPhotosmart C5280
scanner. FIJI was used to quantify the bands in arbitrary
densitometry units. The density of bands corresponding
to full-length tau (50–70 kDa) was determined and
normalised against amount of GAPDH. These values
were used to calculate the proportion of total tau that is
phosphorylated, expressing the proportions as a
percentage of the buffer-treated control group. For the
quantification of Triton-insoluble and soluble protein, the
proportion of tau in the insoluble and soluble fraction
was calculated using the equations: insoluble/(solu-
ble + insoluble)or soluble/(soluble + insoluble) respec-
tively, and expressed as a percentage of the respective
soluble or insoluble control value.
Immunofluorescence
Cell culture medium was aspirated from dSH-SY5Y
cells andwashedoncewithPBS.Cellswere fixed in 4%
(w/v) paraformaldehyde (PFA) in PBS for 15 min
followed by three washes in PBS. For permeabilization,
the cells were incubated in 0.25% (v/v) Triton X-100 in
PBS for 10 min. Cells were blocked in 2% (w/v) BSA in
PBS for 1 h. Primary antibodies diluted in 2% (w/v) BSA
in PBS and were incubated with the cells for 1 h. The
primary antibodies and dilutions used were as follows:
AT180 (anti-pT231) (1:250) (Thermo Scientific), AT8
(anti-pS202-T205) (1:500) (Thermo Scientific) and
Tau1 (dephosphorylated tau at S195, 198, 199 and
202) (Merck Millipore) [43]. Cells were incubated with
goat anti-mouse-Alexa Fluor® 594 (1:1000) (Invitro-
gen™, Thermo Scientific) diluted in 2% (w/v) BSA in
PBS for 1 h in the dark. Cells were washed three times
in PBS between antibody incubations. Cells were
mounted onto glass slides using ProlongTM Gold
Antifade Moutant with DAPI (Thermoscientific) mount-
ing medium containing 4,6-diamidino-2-phenylindole
(DAPI). Mounted slides were stored in the dark at room
temperature for 24–48 h before imaging and kept at
4 °C for long-term storage. Cells were imaged using
Leica SP8 confocal microscope.
Labelling of acidic organelles
Cells were plated on 35-mm dishes on a 1.5-mm
coverslip (Mattek). Following differentiation, dGAE-488
(5 μM) was added to the cells for 24 h. For labelling
lysosomes and endosomes, LysoTracker® red (Life
Technologies) was diluted in culture media at a final
concentration of 50 nMand incubated for 90 min before
imaging using a Leica SP8 confocal microscope.
Confocal microscopy
All confocal microscopy imaging was carried using
a Leica SP8 confocal microscope. The instrumental., Paired Helical Filament-Forming Region of Tau (297–391)
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5Tau297-391 (dGAE) influences endogenous Tausetting used PMT 3 and PMT Trans channels/lasers
and images were acquired with a HC PLAPoCs2 63 x/
1.40 oil-immersion objective lens. Samples were
scannedsequentially toprevent spectral bleed through.
All images were collected as Z-stacks for all channels
using a step size of 0.5 μm. Five to ten Z-stacks were
taken for each sample, and each experiment was
repeated three times or more. Tomonitor live uptake of
dGAE-488, the environment was maintained at 37 °C
with humidified CO2 and the Adaptive Focus Control
feature was used to maintain constant focal planes
throughout the course of the experiment.
Processing cells for TEM
dSH-SY5Y cells were treated with Alexa Fluor®
488 containing buffer, or 10 μM freshly prepared
dGAE-488 for 24 h. The cells were washed once in
PBS, scraped into a tube and centrifuged at 500g for
5 min. The media was removed and the cells were
suspended in a 1:1 mixture of pre-warmed culture
media: 4% (v/v) PFA for 15 min at 37 °C. The cells
were centrifuged at 500g for 5 min and the cells
were resuspended in fresh 4% (v/v) PFA and 0.1%
(v/v) glutaraldehyde (GA) in 0.1 M phosphate buffer
(pH 7.4) for 3 h at room temperature. The fixed
cells were centrifuged at 1000g for 5 min.
The supernatant was discarded, and the pellet was
suspended in 50 mM glycine in PBS for 10 min at
room temperature. The cells were centrifuged at
1000g for 5 min, and the pellet was washed three
times with 0.1 M cacodylate buffer (pH 7.4). Around
200 μl 4% (w/v) low melting point agarose was
added to the cells and immediately centrifuged at
1000g for 10 min at 30 °C. The tube was immedi-
ately transferred to 4 °C or on ice for 20 min to
solidify the agarose. The agarose-embedded cell
pellet was transferred to a new tube and washed 2–3
times with 0.1 M cacodylate buffer (pH 7.4). The
pellet was post-fixed in a reduced osmium solution
(1% (v/v) osmium tetroxide, 1.5% (w/v) potassium
ferrocyanide in 0.1 M cacodylate buffer, pH 7.4) for
1 h at 4 °C followed by washing three times in 0.1 M
cacodylate buffer (pH 7.4) and three times in double-
distilled H2O for 5 min each. The pellet was
dehydrated in an ethanol series consisting of 30%,
50%, 75%, 90% and 95% ethanol for 15 min each at
4 °C followed by three incubations in 100% ethanol
for 20 min each at 4 °C. The sample was then
infiltrated in a 2:1 mixture of 100% ethanol:Unicryl™
resin (for 30 min followed by a 1:2 mixture of 100%
ethanol:Unicryl™ resin (BBI Solutions) for 30 min.
Finally, the pellet was transferred to a BEEM capsule
(Agar Scientific) and infiltrated in complete Unicryl™
resin overnight at 4 °C. The resin was cured using
light polymerisation for 48 h by illumination from
the underside of the BEEM capsules from a 12 V,
100 W type 6834 Philips projection lamp at a
distance of 35 cm. Ultrathin sections (70 nm) werePlease cite this article as: S. J. Pollack, J. Trigg, T. Khanom, et
Influences Endogenous Tau Protein and Accumulates in A..., Journataken using a diamond knife on a Leica EM UC7
ultramicrotome fitted with a Leica M80 microscope
(Leica Microsystems) and placed on 300 Mesh
Hexagon Nickel 3.05-mm grids (Agar Scientific Ltd)
before proceeding with immunogold labelling.
Immunogold labelling TEM
A modified PBS (pH 8.2) containing 1% BSA,
500 μl/L Tween-20, 10 mM Na-EDTA and 0.2 g/L
NaN3 (termed PBS+) was used throughout the
following procedures for all dilutions of antibodies
and gold probes. The ultrathin sections were initially
blocked using normal goat serum (diluted 1:10
dilution in PBS+; Sigma-Aldrich) for 30 min at
room temperature and then incubated with anti-
Alexa Fluor® 488 primary antibody (1:50) (Thermo
Scientific). The sections were washed three times in
PBS+ for 2 min each followed by incubation with 10-
nm gold particle-conjugated goat anti-rabbit IgG
secondary probe at a 1:10 dilution in PBS+ for 1 h
at room temperature. The sections were washed
three times in PBS + for 10 min each and four times
in distilled water for 5 min each. Immunogold-
labelled thin sections were subsequently post-
stained in 2% (w/v) uranyl acetate for 1 h before
imaging on the TEM.
Image analysis
FIJI (https://fiji.sc) imaging processing package
[44] was used for all image analysis. For quantification
of fluorescence intensities, images were Z-projected to
maximal intensity. Five to ten fields of view were taken
from each condition, and an average of 50 cells per
condition were subjected to analysis. Firstly, a region of
interest (the cell body) was drawn around an individual
cell, excluding cells that had fused nuclei. Area-
integrated intensity and mean grey value were
measured as well as three selections from around the
cell with no fluorescence (background). The corrected
total cell fluorescence (CTCF) was then calculated as
CTCF = integrated density − (area of selected cell ×
mean fluorescence of background readings.
For quantification of internalised dGAE-488, a
focal plane from the middle of the cell that contained
maximal DAPI fluorescence was selected and
subjected to analysis.
Data analysis
Data and statistical analyses were performed using
Microsoft Excel and GraphPad Prism 7. All data are
expressed as the mean ± SEM. When comparing two
groups, Student's unpaired t-test with Welch's correc-
tion was used to determine statistical significance.
When comparing more than two groups, one-way
ANOVA with Dunnet's post-hoc test was used toal., Paired Helical Filament-Forming Region of Tau (297–391)
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6 Tau297-391 (dGAE) influences endogenous Taudetermine differences between experimental groups
and a control group. Differences were considered to be
statistically significant if p b .05.
Results
dGAE and dGAE-488 form structurally and
morphologically similar fibrils
Soluble dGAE was fluorescently labelled using an
Alexa-fluor 488® tag (dGAE-488) to enable inter-
nalisation of dGAE assemblies to be monitored andFigure 1. dGAE and dGAE-488 self-assemble to form struc
at 100 μM for 72 h. Aliquots of assembly mixture were taken
TEM, SDS-PAGE gel electrophoresis and CD spectroscopy.
agitation. The scale bar represents 500 nm. Middle panel is a h
bar, 200 nm). (b) Non-reducin24g SDS-PAGE gel of dGAE a
fluorescence (right panel). Black arrowheads point to monome
CD spectra of the whole assembly mixture for dGAE and dGA
Please cite this article as: S. J. Pollack, J. Trigg, T. Khanom, et
Influences Endogenous Tau Protein and Accumulates in A..., Journato distinguish exogenous dGAE from endogenously
expressed tau. On average, there were 0.1 mol of
488 dye per mole of protein after every labelling
reaction. The Alexafluor-tag® labels amino groups at
the N terminus and on lysine residues, and hence,
we examined the tagged and untagged dGAE using
TEM, SDS-PAGE and CD spectroscopy to determine
whether the label affects aggregation and/or filament
formation. Using the non-reducing conditions for
aggregation established previously [41], dGAE and
dGAE-488 produced morphologically similar short
twisted fibrils (Figure 1(a)). SDS-PAGE of dGAE and
dGAE-488 showed the presence of both the 10/20-kDaturally similar fibrils. dGAE and dGAE-488 were incubated
before (0 h) and after (72 h) fibrillisation for negative-stain
(a) Electron micrographs of dGAE species at 0- and 72-h
igher magnification of the white box in the left panel (scale
nd dGAE-488 shown as Coomassie stain (left panel) and
rs and dimers, tetramers and insoluble fibrils in the well. (c)
E-488 at 0- and 72-h agitation.
al., Paired Helical Filament-Forming Region of Tau (297–391)
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7Tau297-391 (dGAE) influences endogenous Tauand of the 12/24-kDa forms (monomer/dimer), with
the latter predominating in the non-agitated dGAE
preparation at 0 h. We have previously shown that
dGAE is random coil at 0 h and consists mainly of SDS
soluble monomer and dimer, although the solution
likely contains a mixture of low molecular weight
species. Over time, the dGAE self-assembles to form
β-sheet rich filaments [41]. The dGAE-488 preparation
showed slightly increased intensity of dimer bands at
0 h. Electronmicrographs of the proteins at 0 and 72 h
show similar size species in both the dGAE and dGAE-
488 preparations (Figure S1), with round species at 0 h
ranging from10 to80 nm indiameter (FigureS1Aii) and
fibrils at 72 h ranging from 20 to 350 nm in length
(FigureS1Bii). After fibrillisation induced by agitation for
72 h, there was less of the 12-kDa monomeric form of
dGAE compared with dGAE-488, and more of both
preparations were retained in the gel well [41]. CD
spectra were similar for both preparations, with similar
intensityminima at 198 nm (predominantly random coil
conformation) at 0 h and the expected decrease in
random coil signal by 72 h, which accompanied an
increase in insolubleβ-sheet structureswith aminimumFigure 2. Exposure to aggregated dGAE but not soluble (mo
(100 μM) was agitated for 72 h to produce fibrils. Soluble (0 h
and left to incubate for 24 h. (a) Representative wide-fie
ReadyProbes® reagent, showing total nuclei in blue and nucle
(b) The percentage cell death was quantified for all conditions.
from four to six independent experiments ± SEM. A one-way A
11.26, R2 = 0.12, p b .0001). Dunnett's multiple comparisons
buffer only (21.6% ± 1.6%) and cells treated with dGAE fibrils
buffer-treated cells and soluble dGAE-treated cells (24.1% ± 1
Please cite this article as: S. J. Pollack, J. Trigg, T. Khanom, et
Influences Endogenous Tau Protein and Accumulates in A..., Journaaround 218 nm.We have previously demonstrated the
β-sheet signal at 218 nm in the pellet following
centrifugation to separate it from supernatant [41].
Extracellularly applied aggregated dGAE but not
soluble dGAE induces acute cell death
Aggregated dGAE (100 μM agitated for 72 h) and
soluble dGAE (100 μM 0 h, no agitation) were
applied at a concentration of 1 μM directly to dSH-
SY5Y cells and incubated for 24 h. Cell viability was
measured after 24 h using the ReadyProbes® assay
to measure cell death (Figure 2(a)). Although there
was some increase in the percentage of dead cells
due to soluble dGAE compared with buffer treat-
ment, this did not reach statistical significance
(Figure 2(b)). There was a significant increase in cell
death following incubation with aggregated dGAE
(34 ± 2.9%, p b .0001) compared with buffer only
control (21.6% ± 1.6%). Increasing the concentration
of soluble dGAE up to 20 μM produced no further
increase in cell death after incubation for 24 h (figure
S2). dGAE and dGAE-488 showed comparable effectsnomer/dimer) dGAE results in increased cell death. dGAE
) or aggregated (72 h) species (1 μM) were added to cells
ld images following exposure to buffer or dGAE with
i of dead cells in green. The scale bar represents 100 μm.
Data are presented as mean values from six fields of view
NOVA shows a significant difference between groups (F =
show a significant difference between cells treated with
(72 h dGAE) (34.0% ± 2.9%) (p b .0001) but not between
.2%).
al., Paired Helical Filament-Forming Region of Tau (297–391)
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8 Tau297-391 (dGAE) influences endogenous Tauon cell death following the incubation of cells with 1 μM
soluble or aggregated protein, although the soluble
form of dGAE-488 was marginally more toxic, but with
no difference after 72 h fibrillisation (figure S3).
Labelled dGAE-488 is internalised by dSH-SY5Y
cells
Next, we investigated the uptake of soluble and
aggregated dGAE into dSH-SY5Y cells and exam-
ined whether aggregation state affects the efficiency
of internalisation. We used the labelled dGAE-488
form to permit uptake to be visualised and measured
having corrected for total cell fluorescence. Soluble




Buffer 0 h dGAE 72 h dG
(c)
00:00:00 02:00:00 10:00:00
Figure 3. Soluble dGAE-488 readily internalises into dSH-S
agitated (aggregated) dGAE was added to the media of dS
microscopy after 24-h exposure. All scale bars represent 20 μ
quantified from the middle of the z-stack from N = 273 cells from
(72 h) from three independent experiments. An unpaired t-test w
fluorescence intensity between 0 h (1114 ± 66.75 AU) and 72
p b .0001). Data are shown asmean ± SEM. (c) Internalisation
using confocal microscopy from t = 0 h to t = 14 h. 488-positi
neurites from 2 h following the initial addition of dGAE-488 (w
magnification images of internalised soluble dGAE-488 after 24
arrow) and larger perinuclear accumulation (red arrow). The s
middle of the cell body for all panels.
Please cite this article as: S. J. Pollack, J. Trigg, T. Khanom, et
Influences Endogenous Tau Protein and Accumulates in A..., JournadSH-SY5Y cells at 1 μM for 24 h. Confocal micros-
copy analysis showed that following exposure to
soluble dGAE-488, fluorescence was observed
within the cells as punctate staining (Figure 3(a)).
Aggregated dGAE-488 was internalised significantly
less efficiently than the soluble form (474 ± 96
versus 1114 ± 67 AU per cell, p b .0001; Figure 3
(b)), and larger accumulations of dGAE-488 fluores-
cence could be observed outside the cells. Live cell
imaging was used to monitor the internalisation of
soluble dGAE-488. Some dGAE-488 remains out-
side cells and increases in brightness and size over
time, consistent with some continued assembly in
the medium. Internalised dGAE-488 could be de-




Y5Y cells. (a) 1 μM soluble dGAE-488 (unagitated) or 72-h
H-SY5Y cells and then fixed and visualised by confocal
m. (b) The 488 fluorescence intensity in the cell body was
six independent experiments (0 h) and from N = 120 cells
ithWelch's correction shows a significant difference in 488
h (474.1 ± 95.97 AU) (t = 5.475, df = 237.7, R2 = 0.112,
of 5 μM soluble dGAE-488 (unagitated) was monitored live
ve puncta can be seen internalised into the cell body and
hite arrows). The scale bar represents 50 μm. (D) Higher
-h exposure show a punctate pattern in the cell body (white
cale bar represents 15 μm. One z-slice is shown from the
al., Paired Helical Filament-Forming Region of Tau (297–391)
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Figure 4. Exposure to dGAE-488 leads to an accumulation of endogenous phospho-tau in dSH-SY5Y cells. Soluble
dGAE-488 of 1 μM (unagitated) was added to the media of dSH-SY5Y cells for 24 h. Cells were immunolabelled for
endogenous tau using p-tau antibodies (ai) AT180, (bi) AT8 and (ci) dephosphorylated Tau-1. One z-slice is shown from
the middle of the cell body. Orthogonal views are displayed in ai and bi to show potential colocalisation of dGAE-488 with
endogenous tau. The scale bar represents 20 μm. Each panel shows quantification of fluorescence intensity as a
percentage of buffer-treated cells. (aii) Quantification of AT180 fluorescence (N = 69 cells (buffer), 76 cells (dGAE) from
four independent experiments). An unpaired t-test with Welch's correction shows a significant difference in AT180
fluorescence intensity between dGAE- (143.5% ± 7.8%) and buffer-treated cells (100% ± 5.2%) (t = 4.702, df = 128.2,
R2 = 0.1471, p b .0001). (bii) Quantification of AT8 fluorescence. N = 348 cells (buffer), N = 338 cells (dGAE) from three
independent experiments. An unpaired t-test with Welch's correction shows a significant difference in AT8 fluorescence
intensity between dGAE- (270.7% ± 22.5%) and buffer-treated cells (100% ± 3.51%) (t = 7.103, df = 353.4, R2 = 0.1249,
p b .0001). (cii) Quantification of Tau1 fluorescence. N = 68 cells (buffer), 96 cells (dGAE) from three independent
experiments. An unpaired t-test with Welch's correction shows a significant difference in Tau-1 fluorescence intensity
between dGAE (59.17% ± 3.6%) and buffer-treated cells (100% ± 7.3%) (t = 5.011, df = 99.84, R2 = 0.201, p b .0001).
9Tau297-391 (dGAE) influences endogenous Tau
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10 Tau297-391 (dGAE) influences endogenous Tauuptake was found to increase over time (Figure 3(c)).
By 24 h, both distinct punctate staining pattern and
larger perinuclear accumulations were observed
(Figure 3(c) and (d)). Although the time intervals of
the live-cell imaging did not allow for detailed
examination of intracellular transport, the interna-
lised dGAE-488 was observed being trafficked along
the processes (Figure S4 movie).
Internalised dGAE-488 leads to increased
phosphorylation of endogenous tau
Our results suggest that incubation with aggregated
dGAE leads to significant cell death after incubation for
only 24 h, whereas soluble dGAE is internalised but
doesnot appear to be significantly toxic followinga24-h
incubation. Therefore, we investigated whether inter-
nalised soluble dGAE-488 may be capable of altering
the aggregation or phosphorylation state of endoge-
nous tau. Following exposure to soluble 1 μM dGAE-
488, cells were fixed and immunolabelled using
antibodies recognising tau epitopes outside of the
dGAE sequence allowing specific detection of only
endogenous tau (Figure 4(a)–(c)). Cells were exam-
ined for colocalisation of internalised dGAE-488 and
endogenous tau, and the fluorescence intensity of
labelled tau in the cell body was quantified in individual
cells for each antibody. Labelling with AT180 (tau
phosphorylated at T231; pT231) and AT8 (tau phos-
phorylated at 202–205; pS202–pT205) was largely
absent in buffer-treatedcells, but increasedsignificantly
following incubation with soluble dGAE-488, with some
cells showing colocalisation of dGAE-488 with phos-
phorylated endogenous tau (Figure 4(a) and (b)). We
have previously shown that tau dephosphorylated
between amino acids 192–204 detected, using Tau-1
antibody, is found in the nucleus in dSH-SY5Y cells
[43]. Here,we identified tau-1 labelling in the nucleus as
expected but found that there was no colocalisation
with dGAE-488. Quantification of Tau-1 fluorescence
showed a significant decrease in fluorescence intensity
in cells treatedwith dGAE-488 (Figure 4(c)), whichmay
indicate that the tau becomes phosphorylated.
Exposure of cells to soluble dGAE-488 leads to
an increase in triton-insoluble endogenous tau
Western blots of the whole cell lysates were
performed to examine the effect of exogenously
applied dGAE on endogenous tau phospho-epitopes.
Comparison of cells incubated with soluble dGAE with
buffer-treated control cells revealed no change in levels
of total tau and marginal increases in AT8 or AT180
immunoreactivity that did not reach statistical signifi-
cance. Whilst western blots measure total levels of
phospho-tau in cells, immunofluorescent imaging is
able to highlight subcellular localisation of any in-
creases. In order to determine theeffects of internalised
soluble dGAE-488 on the solubility of endogenous tauPlease cite this article as: S. J. Pollack, J. Trigg, T. Khanom, et
Influences Endogenous Tau Protein and Accumulates in A..., Journain neurons, we undertook sequential extraction of tau
protein from cell lysates following solubilisation with 1%
Triton X-100 and centrifugation (16,000g for 30 min).
Following incubation with soluble dGAE for 24 h, there
was a clear redistribution of tau protein immunolabelled
with AT180 from Triton-X 100-soluble to Triton-X 100-
insoluble fractions following incubation with soluble
dGAE compared with buffer-treated controls. dGAE
incubation produced a reduction in soluble tau immu-
noreactive with AT180 (83.0% ± 5.5%, p = .0201) and
an increase in the insoluble form (139.4% ± 14.5%,
p = .0352) (Figure 5(a) and (b)). Unexpectedly, a small
amount of tau was observed in the insoluble fraction of
the buffer-treated control, but the difference between
control and treated cellswas significant. Furthermore, a
new AT8-positive truncated tau species having gel
mobility of 20–25 kDa appeared in the insoluble
fraction. This was more intense in the fraction from
cells incubated with dGAE than with buffer alone.
Internalised dGAE-488 is localised to
perinuclear acidic vesicles
Intracellular fluorescent punctate particles were
observed within the cytoplasm, close to the nucleus
after 24 hof exposure of neurons to soluble dGAE-488.
This staining pattern was consistent with its localisation
in cytosolic vesicles. We therefore examined whether
internalised dGAE-488 was localised to endosomal/
lysosomal compartments. Soluble dGAE-488
was incubated with cells for 24 h and stained with
LysoTracker®, a dye that labels acidic organelles
(lysosomes and late endosomes), for 30 min and then
fixed and visualised by confocal microscopy. There
was a significant increase in the intensity of the
LysoTracker® fluorescence in cells exposed to soluble
dGAE-488 compared to buffer-treated control cells
(211.9% ± 9.9%, p b .0001; Figure 6(ai) and (aii)).
Internalised dGAE-488 showed a strong colocalisation
with LysoTracker® following quantification in Z-stacks
using the Pearson's correlation coefficient (0.8382 ±
0.036, p b .0001; Figure 6(bi) and (bii)).
Internalised dGAE-488 is packaged in vesicular
compartments
TEM was used to examine the ultrastructure of
accumulated tau and dGAE-488 in cells. dSH-SY5Y
were exposed to 10 μM soluble dGAE-488 for
24 h and were processed for immunogold TEM
using an antibody against Alexa Fluor® 488 to label
dGAE-488 specifically. Vesicular structures and
mitochondria were observed within the sectioned
cells confirming that the TEM protocol preserved the
cellular structure (Figure 7(a)). Although no clear fibrillar
structures labelled with anti-488 in the cytoplasm,
examination at higher magnifications revealed the
presence of particles densely labelled with anti-488
within membrane-bound vesicular structuresal., Paired Helical Filament-Forming Region of Tau (297–391)



































Figure 5. Exposure to dGAE for 24 h leads to an accumulation of endogenous phospho-tau in the Triton-insoluble
fraction of dSH-SY5Y cells. (ai) Representative Western blot of SH-SY5Y cell lysate. Soluble dGAE of 1 μM (unagitated)
was added to the media of dSH-SY5Y cells. After 24 h, cells were lysed in RIPA buffer and run on SDS-PAGE. Blots were
probed against total tau, AT180 and AT8. GAPDH was used as a loading control. (aii) The intensity of bands at 50–70 kDa
were quantified for each antibody and normalised against GAPDH. The normalised values for AT180 and AT8 are
expressed as a proportion of total tau (percentage of buffer). Data are shown as mean ± SEM from three independent
experiments. An unpaired t-test shows no significant difference in total tau (p = .3101), AT180 (p = .4662) or AT8 (p =
.2119) immunoreactivity between buffer-treated control and dGAE-treated cells. (bi) Cells were also sequentially lysed in
Triton-X 100 lysis buffer and run on SDS-PAGE. S = Triton-X 100 soluble lysate; I = Triton-X 100 insoluble lysate. The
AT180-antibody was used to detect endogenous phosphorylated tau and GAPDH was used as a loading control. (b) The
proportion of tau in the insoluble and soluble fractions was quantified by densitometry and expressed as a percentage of
buffer-treated controls. Data are shown as mean ± SEM from four independent experiments (one biological repeat per
experiment). An unpaired t-test shows a significant difference in insoluble tau between buffer- (100 ± 0) and dGAE-treated
cells (139.4 ± 14.54) (t = 2.709, df = 6, R2 = 0.5501, p = .0352) and in soluble tau between buffer (100 ± 0) and dGAE-
11Tau297-391 (dGAE) influences endogenous Tausuggesting an accumulation of 488-labelled protein
in these organelles (Figure 7(c)). Similar vesicular
structures were also present in vehicle-treated cells
but lacked gold labelling. Analysis to compare diame-
ters of the membrane-bound compartments
that showed neurons treated with dGAE-488 cells
contained vesicles of larger diameter than buffer-
treated control cells (448.4 ± 22.5 nm versus
303.7 ± 20.0 nm, p b .0001), with the largest vesicles
being 700–800 nm and smallest being 200–300 nm
(Figure 7(b)).Please cite this article as: S. J. Pollack, J. Trigg, T. Khanom, et
Influences Endogenous Tau Protein and Accumulates in A..., JournaDiscussion
Previous studies investigating the properties of
exogenously applied tau in tissue culture cell models
have been hampered by the use of non-neuronal or
neuronal in vitromodels that overexpress human wild-
type or mutant tau, often using non-physiological
fragments or preparations of tau to initiate aggregation
[19,24,25].We have previously reportedmorphological
similarities between filaments formed in vitro from
dGAE and PHFs found in AD brain tissue [41,42].al., Paired Helical Filament-Forming Region of Tau (297–391)
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Figure 6. Internalised soluble dGAE-488 is localised to acidic vesicles in dSH-SY5Y cells. (ai) Representative
immunofluorescence images of cells exposed to 1 μM soluble dGAE-488 (unagitated) for 24 h. Cells were labelled with
LysoTracker® to stain for acidic vesicles including lysosomes and endosomes, and were imaged live. dGAE-488 and
LysoTracker® labelling is mainly localised in the cell body (white arrows). One z-slice is shown from the middle of the cell
body. The scale bar represents 50 μm. (aii) Quantification of LysoTracker® fluorescence intensity as a percentage of
buffer-treated cells. Data show mean ± SEM pooled from three independent experiments. N = 170 cells (buffer), N = 146
cells (dGAE). An unpaired t-test with Welch's correction shows a significant difference in LysoTracker® fluorescence
intensity between dGAE (211.9% ± 9.89%) and buffer-treated cells (100% ± 5.23%) (t = 10, df = 222.6, R2 = 0.3101,
p b .0001). (bi) Higher magnification of a single cell labelled with LysoTracker® containing internalised dGAE-488. The
last panel displays orthogonal views to show colocalisation of dGAE-488 with LysoTracker®. One z-slice is shown from the
middle of the cell body. The scale bar represents 10 μm. (bii) Normalised values of fluorescence intensity for 488 (green)
and LysoTracker (red) along the region indicated by the white line (20 μm) in the last panel in (bi). Colocalisation of dGAE-
488 and LysoTracker® is confirmed by the Pearson's correlation coefficient between the green and red channel. The
average Pearson's R value was 0.8382 ± 0.036 (p b .0001 for each cell) (N = 7 cells).
12 Tau297-391 (dGAE) influences endogenous TauAggregation of dGAE does not require exogenous
seeding factors, and it is possible to control its
fibrillisation in vitro [41]. This has permitted us to
develop a new model system to investigate the
internalisation, cytotoxicity and effect on endogenous
tau of the PHF-forming region of tau in human neuronal
cells in the absence of mutant tau overexpression or
exogenous seeding factors.
In the time frame of these experiments (24 h), we
observed an increase in cell death following expo-
sure of differentiated neuroblastoma cells to aggre-
gated dGAE but minimal differences in the viability of
cells treated with soluble dGAE. Previous studies
have reported that full-length tau, mutated tau and
tau aggregates with different phosphorylation states
have minimal effects on cell viability [45–47]. For
instance, it was observed that oligomers formed from
a variant repeat tau fragment (corresponding to
tau244–372 with a Lys-280 deletion; TauRDΔK) are
selectively toxic to dendritic spines without affecting
cell viability [47]. In contrast, other studies havePlease cite this article as: S. J. Pollack, J. Trigg, T. Khanom, et
Influences Endogenous Tau Protein and Accumulates in A..., Journashown that toxicity is dependent on the precise
fragments of tau that are used [15,48–50]. Variation
in tau toxicity assays may be related in part to the
differences in tau fragments used and in their
methods of tau preparation. Under conditions used
here, aggregated dGAE appeared to be more
acutely toxic to differentiated neuroblastoma cells
following the 24-h incubation period.
Although minimally toxic even at higher concen-
trations, the dGAE in its soluble form was neverthe-
less internalised into differentiated neuroblastoma
cells within 2-h exposure. This is consistent with
previous studies using fluorescently labelled K18
(tau244–372) [28,51] and monomers of full-length
tau carrying the pathogenic P301L mutation [46].
After agitation, the dGAE-488 is internalised much
less efficiently. This is consistent with another report
indicating that heparin-induced tau fibrils and tau
filaments extracted from transgenic mice are not
readily taken up by cells [26]. In our study, we
observed some internalisation using aggregatedal., Paired Helical Filament-Forming Region of Tau (297–391)
l of Molecular Biology, https://doi.org/10.1016/j.jmb.2020.05.027
Figure 7. Internalised soluble dGAE-488 is localised to vesicular structures in dSH-SY5Y cells. dSH-SY5Y cells were
exposed to 1 μM soluble dGAE-488 (unagitated) for 24 h and were processed for immunogold electron microscopy. Anti-
488 antibody was used to label dGAE, detected by 10-nm gold particles. (a) Electron micrograph showing preserved
ultrastructure of cells, with the main cellular compartments labelled: n, nucleus; nu, nucleolus; m, mitochondria; v, vesicular
structure. Red arrowheads point to vesicular structures. The black outlined image represents a magnified image of the
area in the white box. Left: the scale bar represents 5 μm. Right: the scale bar represents 1 μm. (b) Quantification of
vesicle diameter. Data are shown as mean ± SEM pooled from two independent experiments. N = 34 vesicles (buffer),
N = 45 vesicles (dGAE-488). An unpaired t-test showed a significant difference in vesicle diameter between buffer
(303.7 ± 20.03) and dGAE-treated cells (478.4 ± 22.48) (t = 5.601, df = 77, p b .0001, R2 = 0.2895). (c) Higher
magnification electron micrographs of vesicular structures from buffer-treated cells and dGAE-488 treated cells. Blue
arrowheads point to some examples of gold particles. The scale bar represents 200 nm.
13Tau297-391 (dGAE) influences endogenous Taupreparations but this may be due to soluble or
partially soluble species that remain in solution
during preparation of filaments. It is likely that the
agitated dGAE-488 contains a mixture of sizes of tau
assemblies, some of which are internalised and
some of which are not. Whilst the exact species
being internalised remains to be resolved, the
soluble dGAE preparation consists of aggregates
ranging in diameter from 10 to 80 nm implying a
manifold of oligomeric forms (Figure 1(a)). Ongoing
studies seek to address this question by separating
low molecular weight, oligomeric and fibrillar spe-
cies. The inherent assembly-competence of dGAE
may contribute both to its internalisation and seeding
activity [41]. Furthermore, the time taken for 0 hPlease cite this article as: S. J. Pollack, J. Trigg, T. Khanom, et
Influences Endogenous Tau Protein and Accumulates in A..., JournadGAE to become toxic may be longer than the time
frame of these experiments. Extracellular tau has
been shown to bind to exogenous heparan sulphate
proteoglycans and to enter cells by micropinocytosis
in human embryonic kidney (HEK) cells and primary
rodent neurons [23,26]. On the other hand, two
potential uptake mechanisms for monomeric tau
(wild-type and P301S) into human stem-cell derived
neurons have been reported: a rapid endocytic
phase, and a slower micropinocytosis phase [51].
Heparin-induced aggregated tau (P301S) entry was
shown to be largely dependent on endocytosis. The
internalisation we have described does not require
exogenous factors either for aggregation or for
cellular uptake.al., Paired Helical Filament-Forming Region of Tau (297–391)
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14 Tau297-391 (dGAE) influences endogenous TauWe have investigated whether endogenous tau
could be recruited and converted into insoluble forms
following uptake of soluble dGAE into the cytoplasm.
The interaction of between endocytosed tau with
cytosolic tau has been investigated previously in
various cell models that have required the overexpres-
sion of human tau [23,25,52], or by introducing
exogenous tau with the help of protein delivery
reagents [24]. The data presented here show that
incubation with soluble forms of dGAE results in a local
increase in endogenous phospho-tau in cells alongside
normal levels of endogenous tau, consistent with tau
pathology in AD. Using dGAE-488 together with
antibodies recognising epitopes outside the repeat
domain to probe the phosphorylation state of endog-
enous tau protein, we have shown that there is an
increase in phosphorylation of endogenous tau at T231
and S202–T205. These changes are accompanied by
an increase in levels of insoluble phosphorylated tau
protein after sequential extraction, but not in the whole
lysate. Western blots from whole lysate did not reveal
any clear differences in phospho-tau levels using AT80
or AT180,whichmay suggest that overall levels remain
constant, but that local phospho-tau levels increase
within areas of insoluble/aggregated tau as shown by
immunofluorescence and following sequential extrac-
tion. The mechanism of induction of aggregation or
increased phosphorylation following uptake of soluble
forms of dGAE is not known at this stage. This
truncated tau species is able to self-assemble sponta-
neously without any requirement for phosphorylation.
Here we show that dGAE co-aggregates with endog-
enous tau and that these accumulate together within
endosomal/lysosomal compartments. Further studies
are ongoing to better characterise the nature of the
intracellular processing and co-aggregation with en-
dogenous tau that leads to accumulation in the
endosomal/lysosomal compartment. One scenario
might be that disruption of membranes by dGAE
oligomers permit leakage into the cytoplasm and
interaction with endogenous tau [15,53,54].
It has been reported previously that internalised
tau aggregates colocalise with endosomal and
lysosomal markers [26]. Here, we show that the
majority of dGAE that is internalised by cells is
localised to lysosomal compartments. Using immu-
nogold TEM, we reveal the localisation of dGAE-488
to vesicular structures with a size range suggestive
of lysosomal compartments. The immunofluores-
cence and TEM findings together suggest the
accumulation of both dGAE and endogenous tau
within the endo-lysosomal compartments. These
findings provide a novel perspective on the ultra-
structure of cells following internalisation of a
pathological form of tau and suggest that the
autophagy pathway may be implicated in its degra-
dation, which is consistent with previous studies
[26,28,51]. Future studies involving longer incuba-
tion times will allow us to examine whether thesePlease cite this article as: S. J. Pollack, J. Trigg, T. Khanom, et
Influences Endogenous Tau Protein and Accumulates in A..., Journaaggregates can develop further within lysosomal
compartments and then in the cytosol. In cell-free
and cellular models, the formation of oligomers was
required for a template-directed truncation of tau
protein and this process [22,39] and their clearance
[55] are enhanced by tau aggregation inhibitors.
Physiological and pathological forms of tau are
cleared by the proteasomal and autophagic degrada-
tive systems [56], and it has been suggested that
pathological tau is preferentially degraded by the
autophagic-lysosomal system [57,58]. It is possible
that the accumulation of pathological tau may interfere
with the normal functioning of these degradative
processes. In AD, there is support for impaired
degradation of autophagic vacuoles by lysosomes
[59,60], suggesting that incomplete clearance of
pathological tau could contribute to neuronal dysfunc-
tion. Understanding how accumulated tau species can
be cleared from cells may allow for the development of
complementary therapeutic approaches in addition to
inhibition of tau aggregation.
In conclusion, the work presented here provides a
basis for further research to address unanswered
questions concerning the physiological and patholog-
ical consequences of PHF-core tau self-assembly. The
ease with which soluble dGAE self-assembles and
internalises into neuronal cells makes it possible to
study the effect of its self-assembly in a cellular
environment, in particular its effect on acute toxicity
and its influence on phosphorylation state and insolu-
bility of endogenous tau at an ultrastructural level. This
approach will provide a useful tool to facilitate the study
of tau aggregation in the absence of any overexpres-
sion of the protein, post-translational modification, or
inducers of assembly and ultimately to study the
mechanism of action of tau aggregation inhibitors that
target tau seeding and neuronal transmission in AD
and related tauopathies.Acknowledgments
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